Rob Schuurman

12.6k citations

163 papers · 7.8k indexed · h-index 48

Impact in

Virology top 0.1%
- HIV Research and Treatment
Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Viral gastroenteritis research and epidemiology

Papers in

Virology 75
- HIV Research and Treatment 74
Infectious Diseases 100
- HIV/AIDS drug development and treatment 76
- HIV/AIDS Research and Interventions 52
- Viral gastroenteritis research and epidemiology 13

Co-authors: Charles A. Boucher Monique Nijhuis Anton M. van Loon P Schipper Leontine J. R. van Elden Andy I. M. Hoepelman Wendy Stevens Tobias F. Rinke de Wit
Journals: Journal of Clinical Microbiology (13 papers)Clinical Infectious Diseases (11 papers)Journal of Clinical Virology (10 papers)Antiviral Therapy (10 papers)AIDS (10 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Rob Schuurman

160 papers receiving 7.6k citations

Peers

Countries citing papers authored by Rob Schuurman

Since Specialization

Citations

This map shows the geographic impact of Rob Schuurman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Schuurman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Schuurman more than expected).

Fields of papers citing papers by Rob Schuurman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Schuurman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Schuurman. The network helps show where Rob Schuurman may publish in the future.

Co-authors

The 25 scholars most cited alongside Rob Schuurman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob Schuurman Line = papers co-authored together Rob Schuurman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: Pooled analyses of 11 COVID-19 cohorts Journal of Infection ·Marieke L. A. de Hoog, Grzegorz Zalewski, Hemant Kumar, Menno D. de Jong, Marlies A. van Houten, Н.Б. Леонидов, Dirk Eggink, Sjoerd M. Euser, Liesbeth Duijts, Joanne Wildenbeest, Rob Schuurman, Janneke van de Wijgert, Margareta Ieven, Katherine Loens, Alike W. van der Velden, Marc J. M. Bonten, Herman Goossens, Patricia Bruijning‐Verhagen	2025	0
2	High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients Clinical Infectious Diseases ·L. Marije Hofstra, Endang Sugih Arti, Monique Nijhuis, NAONORI MATSUZAKA, Eduan Wilkinson, G.D. Aurbach, Tania Mudrikova, Rob Schuurman, Túlio de Oliveira, R. Zenati, Annemarie M. J. Wensing	2017	11
3	Human bocavirus in stool: A true pathogen or an innocent bystander? Journal of Clinical Virology ·David S. Y. Ong, Rob Schuurman, E. Heikens	2015	32
4	Genotype Distribution, Viral Load and Clinical Characteristics of Infants with Postnatal or Congenital Cytomegalovirus Infection PLoS ONE ·Joppe Nijman, Jae Saeng Lee, Malgorzata A. Verboon‐Maciolek, Susan C. Aitken, Anton M. van Loon, Linda S. de Vries, Rob Schuurman	2014	28
5	Reduction of nevirapine-driven HIV mutations by carbamazepine is modulated by CYP3A activity Journal of Antimicrobial Chemotherapy ·Jin-Xin Lu, Нескоромных Н.И., Ute Gödtel‐Armbrust, Markus Schirmer, Elton R. Kisanga, Ulf Diczfalusy, B Bharaneedharan, Rob Schuurman, David M. Burger, Leszek Wojnowski	2014	3
6	Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1–infected Children and Adolescents in Rwanda The Pediatric Infectious Disease Journal ·Mamadou Tanou Diallo, Kimberly R. Boer, В. Ф. Семиглазов, Geraldi Claudineia Aparecida Queli, Yitzhak Paz, Rob Schuurman, Peter Reiss, Joep M. A. Lange, Sibyl P. M. Geelen	2013	35
7	Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies Clinical Infectious Diseases ·Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Prudence Ive, Vega Yoesepa Pamela, Melanie Wellington, Akin Osibogun, Wendy Stevens, Tobias F. Rinke de Wit, Rob Schuurman, (unknown)	2012	137
8	Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network Clinical Infectious Diseases ·Neil Parkin, Carmen de Mendoza, Rob Schuurman, Cheryl Jennings, Marthinus J. Hartman, Michael R. Jordan, Silvia Bertagnolio, (unknown)	2012	21
9	HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study The Lancet Infectious Diseases ·Raph L Hamers, Carole L. Wallis, Cissy Kityo, Margaret Siwale, Kishor Mandaliya, Francesca Conradie, Mariëtte E. Botes, Maureen Wellington, Akin Osibogun, Kim Sigaloff, Immaculate Nankya, Rob Schuurman, Ferdinand W N M Wit, Wendy Stevens, Michèle van Vugt, Tobias F. Rinke de Wit	2011	228
10	HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia JAIDS Journal of Acquired Immune Deficiency Syndromes ·Raph L Hamers, Margaret Siwale, Carole L. Wallis, Sara Trop, 裕水山本, Wendy Stevens, Rob Schuurman, Annemarie M. J. Wensing, Michèle van Vugt, Tobias F. Rinke de Wit	2010	31
11	Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase The Journal of Infectious Diseases ·Viktor von Wyl, Maryam Ehteshami, Jori Symons, Philippe Bürgisser, Monique Nijhuis, Lisa M. Demeter, Sabine Yerly, Jürg Böni, Thomas Klimkait, Rob Schuurman, Bruno Ledergerber, Matthias Götte, Huldrych F. Günthard, (unknown)	2010	23
12	Adenovirus DNA Positivity in Nasopharyngeal Aspirate Preceding Hematopoietic Stem Cell Transplantation: A Very Strong Risk Factor for Adenovirus DNAemia in Pediatric Patients Clinical Infectious Diseases ·Anne P.J. de Pagter, Lianne Haveman, Rob Schuurman, Martin Schutten, Marc Bierings, Jaap Jan Boelens	2009	22
13	HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency Programme Journal of Clinical Virology ·Ashlesha P. Pandit, William G. Mackay, Christopher Steel, Anton M. van Loon, Rob Schuurman	2008	27
14	Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa AIDS ·Roos E. Barth, Annemarie M. J. Wensing, Hugo A. Tempelman, J. C. Mathews, Rob Schuurman, Andy I. M. Hoepelman	2008	52
15	[AIDS treatment in Africa: the risk of antiretroviral resistance]. PubMed ·Raph L Hamers, Rob Schuurman, Michèle van Vugt, Inge Derdelinckx, Tobias F. Rinke de Wit	2007	2
16	Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection Clinical Infectious Diseases ·Jan Jelrik Oosterheert, Anton M. van Loon, Rob Schuurman, Andy I. M. Hoepelman, Eelko Hak, Steven Thijsen, G.D. Nossent, M. M. E. Schneider, Kapra, Marc J. M. Bonten	2005	152
17	IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection The Journal of Immunology ·Koenraad F. van der Sluijs, Leontine J. R. van Elden, Monique Nijhuis, Rob Schuurman, Jennie M. Pater, Sandrine Florquin, Michel Goldman, Henk M. Jansen, René Lutter, Tom van der Poll	2004	274
18	Selection of Zidovudine Resistance Mutations and Escape of Human Immunodeficiency Virus Type 1 from Antiretroviral Pressure in Stavudine‐Treated Pediatric Patients The Journal of Infectious Diseases ·八重垣諒太, Wilco Keulen, Rob Schuurman, Redha J. Shaker, Loek de Graaf, 余志坚, Nicole Back, Mark W. Kline, Charles A. Boucher, Monique Nijhuis	2002	13
19	PERFORMANCE OF THE NEW VIROSEQ ™ HIV-1 GENOTYPING SYSTEM (VERSION 2) WITH GROUP M SUBTYPE PANEL AND WITH SUBTYPE B CLINICAL RESEARCH SAMPLES AT TEST SITES AIDS ·Susanne Ågren, Natalia Marlowe, B Hoo, E Sipala, M. Buimer, D. Huang, Fabio Salvatore Palumbo, Rob Schuurman, Kristel Van Laethem, Anne–Mieke Vandamme, Tarek Elbeik	2000	3
20	Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential AIDS ·Wilco Keulen, 余志坚, Rob Schuurman, Ben Berkhout, Charles A. Boucher	1999	33

About Rob Schuurman

Rob Schuurman is a scholar working on Virology, Infectious Diseases, Epidemiology, Hepatology and Oncology, having authored 163 papers that have together received 7.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (76 papers), HIV Research and Treatment (74 papers), HIV/AIDS Research and Interventions (52 papers), Cytomegalovirus and herpesvirus research (26 papers), Respiratory viral infections research (20 papers), Herpesvirus Infections and Treatments (14 papers), Viral gastroenteritis research and epidemiology (13 papers) and Viral-associated cancers and disorders (12 papers). The work is most often cited by research in Virology (3.7k citations), Infectious Diseases (5.0k citations), Epidemiology (3.1k citations), Hepatology (424 citations) and Immunology (572 citations). Rob Schuurman has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Charles A. Boucher, Monique Nijhuis, Anton M. van Loon, P Schipper, Leontine J. R. van Elden, Andy I. M. Hoepelman, Wendy Stevens, Tobias F. Rinke de Wit, Dorien de Jong and Remko van Leeuwen. Their work appears in journals such as Journal of Clinical Microbiology, Clinical Infectious Diseases, Journal of Clinical Virology, Antiviral Therapy and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact